Camacho, Kathryn M <br/><br/>
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.  [electronic resource] 

 -  Journal of controlled release : official journal of the Controlled Release Society  05 2016 
 - 154-162 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-4995 
<br/><br/><label>Standard No.: </label>10.1016/j.jconrel.2016.03.027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Cell Line<br/>Cell Line, Tumor<br/>Doxorubicin--administration & dosage<br/>Drug Combinations<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Liposomes<br/>Mice, Inbred BALB C<br/>Neoplasms--drug therapy<br/>Polyethylene Glycols--chemistry<br/>Tryptophan--chemistry<br/>Tumor Burden--drug effects